Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × neratinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Ovarian Neoplasms 2 Recurrence 1 Pathologic Complete Response 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 HER2-positive Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1 Disease 1 Central Nervous System Neoplasms 1 Carcinoma, Lobular 1 Breast Cancer With Brain Metastasis 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡